N-{1-[4-({6-[3-(Cyclopropylmethoxy)phenoxy]pyridin-3-yl}methoxy)phenyl]ethyl}acetamide

ID: ALA4753303

Chembl Id: CHEMBL4753303

PubChem CID: 134226959

Max Phase: Preclinical

Molecular Formula: C26H28N2O4

Molecular Weight: 432.52

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(=O)NC(C)c1ccc(OCc2ccc(Oc3cccc(OCC4CC4)c3)nc2)cc1

Standard InChI:  InChI=1S/C26H28N2O4/c1-18(28-19(2)29)22-9-11-23(12-10-22)30-17-21-8-13-26(27-15-21)32-25-5-3-4-24(14-25)31-16-20-6-7-20/h3-5,8-15,18,20H,6-7,16-17H2,1-2H3,(H,28,29)

Standard InChI Key:  RCIYLIQKUICBRR-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4753303

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 432.52

Molecular Weight (Monoisotopic): 432.2049

AlogP: 5.44

#Rotatable Bonds: 10

Polar Surface Area: 69.68

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 1.51

CX LogP: 4.40

CX LogD: 4.40

Aromatic Rings: 3

Heavy Atoms: 32

QED Weighted: 0.46

Np Likeness Score: -1.21

References

1. Mizojiri R,Tomita D,Sasaki M,Satoh Y,Yamamoto Y,Sumi H,Maezaki H.  (2021)  Design and synthesis of a monocyclic derivative as a selective ACC1 inhibitor by chemical modification of biphenyl ACC1/2 dual inhibitors.,  35  [PMID:33607488] [10.1016/j.bmc.2021.116056]

Source

Source(1):

• Scientific Literature